• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR

tetano

Editor, Senior Moderator
Nat Commun


. 2022 Jul 21;13(1):4212.
doi: 10.1038/s41467-022-31796-1.
Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR


Kenneth Danh[SUP] 1 [/SUP], Donna Grace Karp[SUP] 1 [/SUP], Malvika Singhal[SUP] 1 [/SUP], Akshaya Tankasala[SUP] 1 [/SUP], David Gebhart[SUP] 1 [/SUP], Felipe de Jesus Cortez[SUP] 1 [/SUP], Devangkumar Tandel[SUP] 1 [/SUP], Peter V Robinson[SUP] 1 [/SUP], David Seftel[SUP] 1 [/SUP], Mars Stone[SUP] 2 [/SUP], Graham Simmons[SUP] 2 [/SUP], Anil Bagri[SUP] 3 [/SUP], Martin A Schreiber[SUP] 4 [/SUP], Andreas Buser[SUP] 5 [/SUP], Andreas Holbro[SUP] 5 [/SUP], Manuel Battegay[SUP] 6 [/SUP], Mary Kate Morris[SUP] 7 [/SUP], Carl Hanson[SUP] 7 [/SUP], John R Mills[SUP] 8 [/SUP], Dane Granger[SUP] 8 [/SUP], Elitza S Theel[SUP] 8 [/SUP], James R Stubbs[SUP] 8 [/SUP], Laurence M Corash[SUP] 3 [/SUP], Cheng-Ting Tsai[SUP] 9 [/SUP]



Affiliations

Abstract

An easily implementable serological assay to accurately detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies is urgently needed to better track herd immunity, vaccine efficacy and vaccination rates. Herein, we report the Split-Oligonucleotide Neighboring Inhibition Assay (SONIA) which uses real-time qPCR to measure the ability of neutralizing antibodies to block binding between DNA-barcoded viral spike protein subunit 1 and the human angiotensin-converting enzyme 2 receptor protein. The SONIA neutralizing antibody assay using finger-prick dried blood spots displays 91-97% sensitivity and 100% specificity in comparison to the live-virus neutralization assays using matched serum specimens for multiple SARS-CoV-2 variants-of-concern. The multiplex version of this neutralizing antibody assay, using easily collectable finger-prick dried blood spots, can be a valuable tool to help reveal the impact of age, pre-existing health conditions, waning immunity, different vaccination schemes and the emergence of new variants-of-concern.
 
Back
Top Bottom